VBLT logo

Vascular Biogenics (VBLT) Total Liabilities

Annual Total Liabilities

$7.21 M
-$5.28 M-42.26%

December 31, 2022


Summary


Performance

VBLT Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherVBLTbalance sheetmetrics:

Quarterly Total Liabilities

$5.41 M
-$2.81 M-34.15%

June 30, 2023


Summary


Performance

VBLT Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherVBLTbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

VBLT Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-42.3%-50.6%
3 y3 years-44.5%-46.6%
5 y5 years-26.4%-37.5%

VBLT Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-42.3%at low-59.9%at low
5 y5-year-44.5%at low-59.9%at low
alltimeall time-79.6%-64.6%-84.7%-44.0%

Vascular Biogenics Total Liabilities History

DateAnnualQuarterly
Jun 2023
-
$5.41 M(-34.1%)
Mar 2023
-
$8.21 M(+14.0%)
Dec 2022
$7.21 M(-42.3%)
$7.21 M(-29.5%)
Sep 2022
-
$10.22 M(-6.6%)
Jun 2022
-
$10.95 M(-18.9%)
Mar 2022
-
$13.49 M(+8.1%)
Dec 2021
$12.48 M(+15.7%)
$12.48 M(+21.2%)
Sep 2021
-
$10.30 M(-10.3%)
Jun 2021
-
$11.48 M(+16.9%)
Mar 2021
-
$9.82 M(-8.9%)
Dec 2020
$10.79 M(-16.9%)
$10.79 M(+0.8%)
Sep 2020
-
$10.70 M(+5.6%)
Jun 2020
-
$10.14 M(-12.8%)
Mar 2020
-
$11.62 M(-10.5%)
Dec 2019
$12.98 M(+71.2%)
$12.98 M(+8.3%)
Sep 2019
-
$11.98 M(+2.1%)
Jun 2019
-
$11.74 M(+10.2%)
Mar 2019
-
$10.65 M(+40.5%)
Dec 2018
$7.58 M
$7.58 M(+0.3%)
DateAnnualQuarterly
Sep 2018
-
$7.56 M(-12.6%)
Jun 2018
-
$8.65 M(-14.7%)
Mar 2018
-
$10.14 M(+3.6%)
Dec 2017
$9.79 M(+100.8%)
$9.79 M(+91.9%)
Sep 2017
-
$5.10 M(-13.7%)
Jun 2017
-
$5.91 M(+28.2%)
Mar 2017
-
$4.61 M(-5.4%)
Dec 2016
$4.87 M(+15.2%)
$4.87 M(+26.0%)
Sep 2016
-
$3.87 M(-8.5%)
Jun 2016
-
$4.23 M(+5.0%)
Mar 2016
-
$4.03 M(-4.8%)
Dec 2015
$4.23 M(+39.4%)
$4.23 M(-18.9%)
Sep 2015
-
$5.21 M(+51.6%)
Jun 2015
-
$3.44 M(+13.6%)
Mar 2015
-
$3.03 M(-0.2%)
Dec 2014
$3.04 M(-91.4%)
$3.04 M(-46.3%)
Sep 2014
-
$5.65 M(-84.0%)
Dec 2013
$35.41 M(+1287.5%)
$35.41 M
Dec 2012
$2.55 M
-

FAQ

  • What is Vascular Biogenics annual total liabilities?
  • What is the all time high annual total liabilities for Vascular Biogenics?
  • What is Vascular Biogenics annual total liabilities year-on-year change?
  • What is Vascular Biogenics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Vascular Biogenics?
  • What is Vascular Biogenics quarterly total liabilities year-on-year change?

What is Vascular Biogenics annual total liabilities?

The current annual total liabilities of VBLT is $7.21 M

What is the all time high annual total liabilities for Vascular Biogenics?

Vascular Biogenics all-time high annual total liabilities is $35.41 M

What is Vascular Biogenics annual total liabilities year-on-year change?

Over the past year, VBLT annual total liabilities has changed by -$5.28 M (-42.26%)

What is Vascular Biogenics quarterly total liabilities?

The current quarterly total liabilities of VBLT is $5.41 M

What is the all time high quarterly total liabilities for Vascular Biogenics?

Vascular Biogenics all-time high quarterly total liabilities is $35.41 M

What is Vascular Biogenics quarterly total liabilities year-on-year change?

Over the past year, VBLT quarterly total liabilities has changed by -$5.54 M (-50.58%)